The Company, together with its wholly owned subsidiaries, is a pharmaceutical and Traditional Chinese Medicine company which develops, manufactures and commercializes both plant-based pharmaceutical and plant-based nutraceutical products.


Updates from The Motley Fool

Latest updates on American Oriental Bioengineering from Fool.com.  The Fool has written over 100 articles on American Oriental Bioengineering.
3 Top Stocks at Half-Price

Investors still think highly of these companies, despite their fire-sale prices.

3 Top Stocks at Half-Price

Investors still think highly of these companies, despite their fire-sale prices.

3 Top Stocks at Half Price

Investors still think highly of these companies, despite their fire-sale prices.

3 Top Stocks at Half Price

Investors still think highly of these companies, despite their fire-sale prices.

The Fool Looks Ahead

Drugs and doughnuts will color in the week that lies ahead.

These Underdogs Are No Dogs

Like the smart hedge fund operators, these CAPS investors bet against a stock -- and won big!

3 Top Stocks at Half Price

Investors still think highly of these companies, despite their fire-sale prices.

3 Top Stocks at Half-Price

Investors still think highly of these companies, despite their fire-sale prices.

Tomorrow's Monster Stock?

A list of promising companies chosen by investors who've already picked stocks that beat the mark...

3 Stocks Making Cash

These three top stocks have a proven history of generating lots of free cash flow.



Stock Performance

View Interactive AOBID Charts
Sponsored by

Key Data Points

Primary metrics and data points about American Oriental Bioengineering.
Current Price: $0.00
Prev Close: $0.00
Open: $0.00
Bid: $0.00
Ask: $0.00
Day's Range: $0.00 - $0.00
52wk Range: $0.00 - $0.00
Volume: 0
Avg Vol 0
Market Cap: $0
P/E (ttm): 0.00
EPS (ttm): ($1,227.50)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about American Oriental Bioengineering.
CAPS Rating 0 out of 5
 
2240 Outperform
87 Underperform
CAPS All Stars
 
341 Outperform
23 Underperform

How do you think American Oriental Bioengineering will perform against the market?



You pick for American Oriental Bioengineering is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


Business Summary

Industry, sector and description for American Oriental Bioengineering.

The Company, together with its wholly owned subsidiaries, is a pharmaceutical and Traditional Chinese Medicine company which develops, manufactures and commercializes both plant-based pharmaceutical and plant-based nutraceutical products.

  • Exchange: NASDAQOTH
  • Sector: Consumer Staples
  • Industry: Personal Products